➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKinsey
Dow
Express Scripts
McKesson
AstraZeneca
Johnson and Johnson

Last Updated: September 21, 2020

DrugPatentWatch Database Preview

Patent: 5,260,336

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 5,260,336
Title: Monounsaturated fat as dietary supplement to minimize the effects of catabolic illness
Abstract:Disclosed is a method of minimizing the effects of a catabolic illness in an individual by administering to the individual a diet which is controlled in the type of fatty acid intake. The diet comprises an oil rich in .omega.9 monounsaturated fatty acids, preferably oleic acid. Oils rich in monounsaturated fatty acids include olive oil, canola oil and high oleic acid safflower or high oleic acid sunflower oil. The diet can also be administered to an individual to minimize infection or to minimize the risk of infection in the individual. A dietary supplement useful in methods of the invention and a structured lipid are also disclosed.
Inventor(s): Forse; R. Armour (Brookline, MA), Mascioli; Edward A. (Needham, MA)
Assignee: New England Deaconess Hospital Corporation (Boston, MA)
Application Number:07/876,189
Patent Claims:see list of patent claims

Details for Patent 5,260,336

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Merck Sharp & Dohme Corp. ZOSTAVAX zoster vaccine live INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION 125123 001 2006-05-25   Start Trial New England Deaconess Hospital Corporation (Boston, MA) 2039-09-23 search
Merck Sharp & Dohme Corp. ZOSTAVAX zoster vaccine live INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION 125123 1 2006-05-25   Start Trial New England Deaconess Hospital Corporation (Boston, MA) 2039-09-23 search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Colorcon
Dow
Boehringer Ingelheim
Mallinckrodt
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.